Literature DB >> 18571352

Evaluation of the use of UPLC-TOFMS with simultaneous [14C]-radioflow detection for drug metabolite profiling: application to propranolol metabolites in rat urine.

T J Athersuch1, R L Sison, A S J Kenyon, J A Clarkson-Jones, I D Wilson.   

Abstract

The non-selective beta-adrenergic receptor antagonist propranolol [1-(isopropylamino)-3-(1-naphthoxy)-2-propanol] is metabolised extensively in vivo. Enumerating and identifying the many metabolites that result from multiple biotransformations provides a considerable analytical challenge, greatly aided by efficient chromatography coupled to sensitive mass spectrometric detection. Here the use of the newly introduced high-resolution technique of "ultra performance liquid chromatography" (UPLC) linked to quadrupole time-of-flight mass spectrometry (TOFMS) with simultaneous [(14)C]-radioflow detection was applied to rapid metabolite profiling. [14C]-propranolol, dosed intraperitoneally to rat at 25 mg kg(-1) and 200 microCi kg(-1) was used as a model compound for this evaluation. Some 14 metabolites were detected in the urine by this technique including a number of conjugated metabolites such as sulphates, several isobaric glucuronides and two novel di-glucuronides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18571352     DOI: 10.1016/j.jpba.2008.05.003

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Metabolism profile of quinocetone in swine by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry.

Authors:  Haixia Wu; Chunyan Yang; Zhanhui Wang; Jianzhong Shen; Suxia Zhang; Peisheng Feng; Linxia Li; Linli Cheng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-20       Impact factor: 2.441

2.  A unique automation platform for measuring low level radioactivity in metabolite identification studies.

Authors:  Joel Krauser; Markus Walles; Thierry Wolf; Daniel Graf; Piet Swart
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.